Daniel P. Petro

Phase II Study of Everolimus (RAD001) in Previously Treated Small Cell Lung Cancer

Ahmad A. Tarhini, Αthanasios Kotsakis, William E. Gooding et al. · Clinical Cancer Research · 2010 · 130 citations

Initial Results of a Multicenter Phase 2 Trial of Stereotactic Ablative Radiation Therapy for Oligometastatic Cancer

Philip Sutera, D.A. Clump, Ronny Kalash et al. · International Journal of Radiation Oncology*Biology*Physics · 2018 · 80 citations

Surgical Oncology, Initial Results, Radiation Therapy +9

SWOG S1400C (NCT02154490)—A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration–Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy)

Martin J. Edelman, Mary W. Redman, Kathy S. Albain et al. · Journal of Thoracic Oncology · 2019 · 75 citations · Full text

Swog S1400c, Medicine, Pathology +9

A Phase I Study of Concurrent Chemotherapy (Paclitaxel and Carboplatin) and Thoracic Radiotherapy with Swallowed Manganese Superoxide Dismutase Plasmid Liposome Protection in Patients with Locally Advanced Stage III Non-Small-Cell Lung Cancer

Ahmad A. Tarhini, Chandra P. Belani, James D. Luketich et al. · Human Gene Therapy · 2010 · 64 citations

Phase 1/2 study of rilotumumab (AMG 102), a hepatocyte growth factor inhibitor, and erlotinib in patients with advanced non–small cell lung cancer

Ahmad A. Tarhini, Imran Rafique, Theofanis Floros et al. · Cancer · 2017 · 39 citations · Full text